Migraine Prevention & Relief
Natural health product licensed in Canada
- Licence holder
- Jensens Labs Inc.
- NPN or DIN-HM
- 80053000
- Status
- Active licence
- Licence date
- 11 August 2014
- Revision date
- Not provided
- Form
- Comprimé, enrobé par pellicule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Saccharomyces cerevisiae - Cellule entière pour biosynthèse | 50 mg | Not calculated |
| Tanacetum parthenium Source : Sommité Potency : 0.5 % Parthenolide | 30 mg | Not calculated |
| L-5-hydroxytryptophane Source : Griffonia simplicifolia, graine | 75 mg | Not calculated |
Non-medicinal ingredients
Cellulose, Acide stéarique, Phosphate dicalcique, Gel de silice, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Comprimé | 2 days |
Uses authorised in Canada
Helps reduce severity and frequency of migraine headaches and associated nausea and vomiting when taken as a prophylactic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. Hypersensitivity, such as an allergy, has been known to occur. Some people may experience sore mouth, mouth ulcers and/or gastrointestinal discomfort. In each case, discontinue use.
- Contre-indications
Do not use: if you are pregnant; if you have scleroderma; if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes.
Source
Official Health Canada record, licence 80053000
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.